Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-633-2 | CAS number: 7664-38-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Health surveillance data
Administrative data
- Endpoint:
- health surveillance data
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Information well reported in the study but repoted results of low interest
Data source
Reference
- Reference Type:
- publication
- Title:
- On phosphates and phosphoric acid as dietary factors in the calcium balance of man.
- Author:
- Malm O J
- Year:
- 1 952
- Bibliographic source:
- Scand J Clin Lab Invest 5 75-84.
- Report date:
- 1952
Materials and methods
- Study type:
- biological effect monitoring
- Endpoint addressed:
- repeated dose toxicity: oral
- Principles of method if other than guideline:
- The experiments to be presented ate the following.
1. Brief ingestion (one week) of 2.37 g orthophosphoric acid daily (750 g P) in four adult men (28, 29, 32 and 43 years of age)
2. Protracted ingestion (four weeks) of 3.16 g of orthophosphoric acid (1000 mg P) daily in two adult men (40 and 43 years of age).
3.Protracted ingestion (eight weeks) of 0.8 g of orthophosphoric acid (250 mg P) daily in four adult men (20, 28, 46 and 56 years of age)
4. Protracted ingestion (twelve weeks) of a neutral (Na -K) phosphate rnixture (600 mg P) daily in two adult rnen (20 and 43 years of age).
All these experiments were carried out in experimental persons who had been observed with regard to their calcium balance for months and years prior to the experiments with addition of phosphoric acid and phosphate. The experiments were carried out under the most careful control of the dietary intake.
In addition, the effect of a very high meat diet (lean beef ) was also studied in four other adult men who were members of the technical staff (27, 28, 38 and 43 years of age) The daily food intalre was measured roughly, and the variations were somewhat larger than in the phosphorus experiments.
It was calculated that the intake of protein was approximately 70-100 g daily during the control period. The protein intake was raised to 210-230 g daily during the seven days of experirnent. The calculated increase in the acidity of the diet was approximately 1200-1400 ml N/10 acid daily. - GLP compliance:
- no
Test material
- Reference substance name:
- Orthophosphoric acid
- EC Number:
- 231-633-2
- EC Name:
- Orthophosphoric acid
- Cas Number:
- 7664-38-2
- Molecular formula:
- H3O4P
- IUPAC Name:
- phosphoric acid
- Details on test material:
- Described in the study report as orthophosphoric acid (84%)
Constituent 1
Results and discussion
- Results:
- No ill effects have been observed during the experiment. The proacted ingestion of the highest dose of phosphoric acid (3.16 g) was felt as a strain.
For the 2.37g dose of phosphoric acid given daily for one week to four men: Phosphoric acid is excreted in the urine with the aid of some reduction of the pH, an increase in the titrable acidity and a slight increase in preformed urinari ammonia. No significant changes in the CO2 combining capacity of the plasma, indicating metabolic acidosis, were found, nor were significant variations observed in the urinary excretion of potassium and total fixed bases.
For the 3.16g dose phosphoric acid given daily for four weeks to 2 men: Phosphoric acid reduce the urinary calcium slightly in the one, somewhat more markedly in the other case. The calcium balance remained unchanged by phosphoric acid administration in both cases.
For the 0.8g dose phosphoric acid given daily for eight week to 4 men: No effect on the calcium balances.
Applicant's summary and conclusion
- Conclusions:
- An increase of P-content of the diet by adding phosphoric acid was followed by a reduction of urinary calcium at all doses and for all persons. The higher the dose is the higher the decrease is. Nevertheless the effects of the 0.8g H3PO4 dose were really moderated.
No ill effects have been observed during the experiment. The proacted ingestion of the highest dose of phosphoric acid (3.16 g) was felt as a strain.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.